| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07062354 Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or… |
Trial sites expanded: 4 -> 8 locations |
| 2026-08-06 | NCT07278739 Testing an Educational Program to Improve Goals of Care Conversations Between Patients… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07498205 | Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low… | Myelofibrosis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04510597 | Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without… | Metastatic Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT03678025 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants… | Castration Levels of Testosterone | Recruiting |
| NCT03418961 | S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+… | Cardiotoxicity | Recruiting |
| NCT05929768 | Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT06470243 | Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT06807437 | Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a… | Pancreatic Carcinoma | Recruiting |
| NCT07018869 | Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC)… | Colorectal Cancer Stage II | Recruiting |
| NCT05642611 | Comparing Cooling and/or Compression Approaches of Limbs for Prevention of… | Malignant Solid Neoplasm | Recruiting |
| NCT06022939 | Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone… | AL Amyloidosis | Recruiting |
| NCT06998940 | Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or… | Locally Advanced Pancreatic Adenocarcinoma | Recruiting |
| NCT05561387 | Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a… | Plasma Cell Myeloma | Recruiting |
| NCT07383441 | Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer | Advanced Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT00070564 | S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With… | Breast Cancer | Active, Not Recruiting |
| NCT04071457 | S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to… | Multiple Myeloma | Active, Not Recruiting |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT03091660 | S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle… | Stage 0 Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT01349881 | S0820, Adenoma and Second Primary Prevention Trial | Colorectal Neoplasms | Active, Not Recruiting |
| NCT05633602 | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent… | Recurrent Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| NCT03757949 | Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be… | Bladder Carcinoma | Active, Not Recruiting |
| NCT07578116 | Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That… | Anatomic Stage IV Breast Cancer AJCC v8 | Not Yet Recruiting |
| NCT07615049 | Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas… | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities | Not Yet Recruiting |
| NCT02785952 | Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating… | Recurrent Squamous Cell Lung Carcinoma | Active, Not Recruiting |
| NCT04155034 | S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus… | Extensive Stage Lung Small Cell Carcinoma | Active, Not Recruiting |
| NCT07220187 | Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter… | Richter Syndrome | Not Yet Recruiting |